Custom Antibody Market
Custom Antibody Market by Service (Development, Purification, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutic), Indication (Oncology, Immunology, Infectious, CVD), Competition, Region - Global Forecast to 2031
CUSTOM ANTIBODY MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global custom antibody market is projected to grow from USD 0.72 billion in 2026 to USD 1.13 billion by 2031, at a CAGR of 9.5% during the forecast period. The market was valued at USD 0.65 billion in 2025. Custom antibodies are antibodies developed or produced to meet specific research or commercial requirements, using technologies such as hybridoma development, recombinant antibody engineering, and phage display. Market growth is fueled by rising investments in pharmaceutical and biotechnology research, increasing demand for targeted biologics, and growing outsourcing of antibody development and production to specialized service providers.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 0.65 Billion
Current Market Size (2026): USD 0.72 Billion
Forecast Market Size (2031): USD 1.13 Billion
CAGR (2026–2031): 9.5% -
SEGMENT LEADERSHIP:
Regional Leader: North America accounted for the largest market share of 41.8% in 2025.
Service Leader: Antibody development accounted for the largest market share of 53.6% in 2025.
Fastest-Growing Type: Monoclonal antibodies are projected to grow at a CAGR of 10.0% during the forecast period.
Source Leader: Mice accounted for the largest market share in 2025.
End User Leader: Pharmaceutical & biotechnology companies dominated the market with a share of 56.7% in 2025. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
GenScript (US), Thermo Fisher Scientific Inc. (US), and Bio-Rad Laboratories, Inc. (US) were identified as some of the star players in the global custom antibody market, given their strong market share and product footprint.
Companies such as ACROBiosystems (US) and CUSABIO TECHNOLOGY LLC (US) have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
The custom antibody market is expected to witness strong growth during the forecast period, driven by increasing investments in biopharmaceutical research, advancements in antibody engineering technologies, and rising demand for application-specific antibodies. Custom antibody services play an important role in research and drug development by providing tailored antibodies that meet specific requirements for target recognition, specificity, affinity, and performance.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The custom antibody market is being shaped by evolving research priorities and pharmaceutical and biotechnology industry trends. The market is expected to witness further transformation during the forecast period, driven by increasing investments in biologics research, growing demand for targeted antibody-based therapeutics, advancements in recombinant antibody technologies, and rising adoption of personalized medicine approaches. Increasing research into complex disease mechanisms and the development of novel therapeutic targets are further expanding the need for application-specific antibodies. These short- and long-term trends are expected to influence demand across pharmaceutical and biotechnology companies, academic and research institutes, and CROs, creating growth opportunities for custom antibody developers and service providers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Growing demand for highly specific antibodies in proteomics, biomarker discovery, and precision medicine
-
Expansion of therapeutic antibody and biologics discovery pipelines
Level
-
High cost of custom antibody development and extensive validation
Level
-
Custom antibodies for spatial biology and multiplex assays
-
Shift toward recombinant and animal-free antibody generation
Level
-
Antibody specificity, reproducibility, and validation issues
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Growing demand for highly specific antibodies in proteomics, biomarker discovery, and precision medicine
Increasing adoption of proteomics, biomarker discovery, and precision medicine is driving demand for custom antibodies with high specificity and affinity. These antibodies support target validation, disease profiling, diagnostic development, and advanced research across pharmaceutical, biotechnology, and academic institutions.
Restraint: High cost of custom antibody development and extensive validation
Custom antibody development involves multiple stages, including antigen design, immunization, screening, purification, and validation, increasing project costs and timelines. These expenses can limit adoption among smaller research laboratories and organizations with constrained R&D budgets.
Opportunity: Custom antibodies for spatial biology and multiplex assays
Growing adoption of spatial biology, multiplex immunoassays, and spatial proteomics creates opportunities for custom antibodies with high specificity and low background. These applications support advanced biomarker profiling across oncology, immunology, neuroscience, and translational research.
Challenge: Antibody specificity, reproducibility, and validation issues
Variations in antigen quality, immune response, clone performance, and assay conditions can affect antibody specificity and reproducibility. Inadequate validation may cause cross-reactivity and unreliable results, highlighting the need for rigorous characterization and application-specific testing.
CUSTOM ANTIBODY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides custom antibody development and production services, including monoclonal, polyclonal, and recombinant antibody generation. Its services cover antigen design, antibody screening, purification, and characterization for research and diagnostic applications. | Supports the development of application-specific antibodies with defined target specificity and performance, helping pharmaceutical companies, biotechnology firms, and academic researchers accelerate target validation and assay development. |
 |
Offers custom antibody production and engineering services through its antibody development capabilities, including GeneArt high-throughput antibody expression, gene synthesis, cloning, transient expression, purification, and quality control. | Enables researchers to obtain custom antibodies for research and development workflows, supporting faster antibody production, consistent quality, and applications in biologics development, protein analysis, and diagnostic research. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The custom antibody market ecosystem comprises a network of interconnected stakeholders, including antigen and reagent suppliers, antibody development service providers, contract research organizations (CROs), distributors, and end users. Raw material suppliers provide essential inputs such as antigens, adjuvants, cell lines, reagents, and purification materials required for antibody development. Custom antibody providers use these inputs and specialized technologies to develop monoclonal, polyclonal, and recombinant antibodies through processes such as immunization, screening, engineering, purification, and characterization. CROs and specialized service providers support antibody discovery, production scale-up, quality control, and application-specific validation. Distributors facilitate access to antibody products and related research reagents, while end users, including pharmaceutical and biotechnology companies, academic and research institutes, and CROs, utilize custom antibodies for target validation, biomarker discovery, diagnostic development, and therapeutic research. This interconnected ecosystem supports efficient antibody development, improves research reproducibility, and expands the use of custom antibodies across diverse life science applications.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Custom Antibody Market, By Service
In 2025, antibody development services accounted for the highest share of the custom antibody market, supported by strong demand for antigen preparation, immunization, hybridoma generation, clone screening, and antibody characterization. Growing biologics research, biomarker discovery, and outsourcing of antibody generation activities continue to support this segment.
Custom Antibody Market, By Type
In 2025, monoclonal antibodies held the largest share of the custom antibody market because of their high specificity, reproducibility, and consistent binding. Their extensive use in research, diagnostics, biomarker validation, and therapeutic development supports their dominant position.
Custom Antibody Market, By Source
In 2025, the mice segment accounted for the highest share by source, owing to the widespread use of mice in hybridoma-based monoclonal antibody development, well-established immunization protocols, and broad availability of validated mouse models for antibody generation.
Custom Antibody Market, By Application
In 2025, research applications held the highest share of the custom antibody market, driven by extensive use of custom antibodies in proteomics, genomics, target validation, biomarker discovery, cell biology, and assay development across academic and biopharmaceutical research.
Custom Antibody Market, By Indication
In 2025, oncology accounted for the highest share by indication, supported by intensive cancer biomarker research, expanding targeted therapy pipelines, and strong demand for antibodies against tumor-associated antigens for research, diagnostics, and therapeutic discovery.
Custom Antibody Market, By End User
In 2025, pharmaceutical & biotechnology companies accounted for the highest share of the custom antibody market, driven by growing biologics pipelines, target discovery programs, preclinical research, biomarker development, and increasing outsourcing of custom antibody development to specialized service providers.
REGION
Asia Pacific to be fastest-growing region in market during forecast period
The Asia Pacific region is expected to be the fastest-growing market for custom antibodies during the forecast period, driven by increasing investments in pharmaceutical and biotechnology research, expanding biopharmaceutical manufacturing capabilities, and rising demand for antibody-based diagnostics and therapeutics. Growing research activities, improving healthcare and laboratory infrastructure, government support for life sciences, and the expansion of CROs further contribute to regional growth. Additionally, increasing collaborations between research institutions and biotechnology companies are supporting the adoption of custom antibody development services across the region.
CUSTOM ANTIBODY MARKET: COMPANY EVALUATION MATRIX
In the global custom antibody market, GenScript (US) is a leading player, supported by its specialized antibody discovery and development capabilities, recombinant antibody technologies, and established relationships with pharmaceutical and biotechnology companies and research institutions. Its custom antibody services span monoclonal and polyclonal antibody development, recombinant antibody generation, antibody engineering, production, purification, and validation, enabling customers to advance antibody-based research, biomarker discovery, and therapeutic development. Labcorp (US) is a prominent player, supported by its extensive contract research capabilities and integrated drug development services. Through its preclinical research and biologics development capabilities, the company supports antibody characterization, analytical testing, and nonclinical evaluation, enabling pharmaceutical and biotechnology companies to advance antibody-based candidates through research and development.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- GenScript (US)
- Thermo Fisher Scientific Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Bio-Techne (US)
- Rockland Immunochemicals, Inc. (US)
- Revvity, Inc. (US)
- Danaher Corporation (US)
- Laboratory Corporation of America Holdings (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 0.65 Billion |
| Market Forecast in 2026 (Value) | USD 0.72 Billion |
| Market Forecast in 2031 (Value) | USD 1.13 Billion |
| Growth Rate | CAGR of 9.5% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
WHAT IS IN IT FOR YOU: CUSTOM ANTIBODY MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Antibody Development Insights | Evaluation of antibody formats, including monoclonal, polyclonal, and recombinant antibodies, based on target specificity, affinity, host system, and intended application. | Supports the selection of suitable antibody formats and improves performance across research, diagnostic, and therapeutic development workflows. |
| Regulatory & Quality Compliance Overview | Review of applicable quality requirements, antibody characterization standards, validation protocols, and documentation requirements for research and development applications. | Strengthens quality assurance, improves reproducibility, and supports compliance with relevant regulatory requirements for intended applications. |
| Technology Comparison | Assessment of antibody development technologies, including hybridoma, phage display, and recombinant antibody expression, based on cost, development timelines, scalability, and suitability. | Enables informed decisions regarding antibody development strategies, technology selection, and project cost optimization. |
RECENT DEVELOPMENTS
- April 2026 : Thermo Fisher opened its US flagship Bioprocess Design Center in Plainville, Massachusetts, to support biopharmaceutical development from early process design through manufacturing, including monoclonal antibody workflows.
- March 2026 : Agilent acquired Biocare Medical, a clinical and research pathology company with a portfolio of 300+ specialized antibodies, IHC reagents, and related pathology solutions. The acquisition directly expands Agilent’s antibody portfolio and strengthens its ability to develop and commercialize new IVD antibodies.
- August 2025 : GenScript entered into a strategic collaboration with Bioelectronica to accelerate therapeutic antibody discovery. The collaboration combines Bioelectronica’s HyperCell high-throughput single B-cell screening and AI-powered AbFinder technology with GenScript’s gene, antibody development, and expression platforms, including TurboCHO.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The global custom antibody market is projected to reach USD 1.13 billion by 2031, up from USD 0.72 billion in 2026, reflecting a 9.5% CAGR over the forecast period. Market estimation involved four major activities to estimate the current size of the custom antibody market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. Following this, data triangulation was used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the custom antibody market. The secondary sources used for this study include Antibody Society, Antibody Therapeutics, Pharmaceutical Research and Manufacturers of America (PhRMA), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), American Medical Association (AMA), Association of Medical Laboratory Immunologists (AMLI), Central Drugs Standard Control Organisation (CDSCO), Center for Drug Evaluation and Research (CDER), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), World Health Organization (WHO), and United States Food & Drug Administration (USFDA).
Secondary sources also include corporate and regulatory filings (annual reports, SEC filings, investor presentations, and financial statements); business magazines & research journals; press releases; trade, business, and professional associations; and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess market prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative data. The following is a breakdown of the primary respondents:
Breakup of Primary Profiles:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the custom antibody market was estimated using multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following.
Custom Antibody Market: Top-Down and Bottom-Up Approach
Data Triangulation
After estimating the market size using the process described above, the total market was divided into several segments and subsegments. To finish the overall market analysis and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown methods were used where applicable. The data were triangulated by examining various factors and trends from both the demand and supply sides.
Market Definition
Custom antibody services include the production of antibodies from a wide variety of host species, depending on the desired outcome of the research study. These services range from antigen preparation, immunization, hybridoma production, and antibody characterization to production, purification, and labeling. The report includes the market size and forecast for custom antibody development, production, purification, and labeling services.
Key Stakeholders
- Academic & Research Institutes
- Custom Antibody Service Vendors
- Contract Research Organizations (CROs)
- Medical Device Companies
- Market Research and Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Private Research Firms
Report Objectives
- To define, describe, and forecast the custom antibody market based on service, type, source, application, indication, end user, and region
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall custom antibody market
- To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, South Korea, India, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East (GCC Countries), and Africa
- To profile the key players and analyze their market share and core competencies
- To analyze competitive developments, such as service launches, partnerships, agreements, collaborations, and expansions
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy
Available customizations:
With the provided market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following options are available for the report:
Geographical Analysis
- A further breakdown of the Rest of Asia Pacific custom antibody market into countries
- A further breakdown of the Rest of Europe custom antibody market into countries
- A further breakdown of the Rest of Latin America custom antibody market into countries
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Segment Analysis
- Cross-segment analysis.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Custom Antibody Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
- Rest Of Europe Custom Antibody Market
- Rest Of Asia Pacific Custom Antibody Market
- Rest Of Latin America Custom Antibody Market
- GCC Countries Custom Antibody Market
- Rest Of Middle East Custom Antibody Market
- Rest Of GCC Countries Custom Antibody Market
- Canada Custom Antibody Market
- US Custom Antibody Market
- Germany Custom Antibody Market
- UK Custom Antibody Market
- France Custom Antibody Market
- Italy Custom Antibody Market
- Spain Custom Antibody Market
- China Custom Antibody Market
- Japan Custom Antibody Market
- India Custom Antibody Market
- South Korea Custom Antibody Market
- Australia Custom Antibody Market
- Brazil Custom Antibody Market
- Mexico Custom Antibody Market
- Saudi Arabia Custom Antibody Market
- UAE Custom Antibody Market
Growth opportunities and latent adjacency in Custom Antibody Market